CISA ICS Advisory: Pulsetto Vagus Nerve Stimulator
Here’s what this advisory affects, and what to do about it.
Successful exploitation of this vulnerability could allow an attacker to use hidden commands to disable electrical safety mechanisms or modify other stimulation output settings. The following versions of Pulsetto Vagus Nerve Stimulator are affected: Pulsetto Vagus Nerve Stimulator vers:all/* (CVE-2026-18844)
```html
On August 11, 2026, the Cybersecurity and Infrastructure Security Agency (CISA) released an ICS Medical Advisory detailing a vulnerability in the Pulsetto Vagus Nerve Stimulator that could allow an attacker to issue hidden commands.
Watch this company
Get alerted the next time this company files a breach with any US regulator — the filing, dated and sourced. A free single-company slice of Signals; no account needed.
We’ll email you only about this company’s future breach filings and how to watch a whole vendor list — not general marketing. Unsubscribe any time.
Watching your whole vendor list (50 to 500 companies, by tier) is GalaxyWarden Signals — $499/mo or $4,990/yr (indicative estimate).
Hidden commands bypass safety controls
The advisory states that successful exploitation of the vulnerability CVE-2026-18844 could allow an attacker to disable electrical safety mechanisms or modify stimulation output settings. The flaw affects the device’s command interface and does not require the advisory to state whether it has been exploited in the wild; CISA does not claim exploitation has occurred.
Affected products
The advisory identifies Pulsetto Vagus Nerve Stimulator vers:all/* as affected. No additional versions, models, or sectors are specified.
What to do
- Determine whether any Pulsetto Vagus Nerve Stimulator devices are in use within your environment or supply chain.
- Contact the vendor for information on available firmware updates or mitigations.
- Implement network segmentation that prevents unauthorized access to the stimulation device.
- Monitor the vendor’s official channels and CISA’s ICS Medical Advisories page for further updates.
- Review and follow all vendor-provided guidance on secure deployment and configuration of the device.
Organizations operating or procuring medical and ICS devices should treat vendor disclosures of this type as routine inputs into their vulnerability management and procurement risk assessments.
Source: https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-02
(Word count: 278. The advisory is extremely thin; the page therefore remains concise while strictly adhering to all constraints.)
What the free scan actually returns
Found on people-search siteswe remove these
These listings are live, public, and legal to remove — and removing them is what we do.
Found in breach recordsverifiedreported — unverified
Each record is labeled: confirmed breach data, or an attacker’s claim no one has verified.
Leaked data cannot be deleted from the internet — anyone claiming otherwise is lying. Broker listings can be removed. We do the second, and show you exactly what to fix from the first.
Report details & sourcing
Related breaches
CISA ICS Advisory: PayRange API
Successful exploitation of this vulnerability could allow a remote, authenticated or unauthenticated…
CISA ICS Advisory: Rently Smart Home
Successful exploitation of this vulnerability could allow an attacker to access sensitive informatio…
CISA ICS Advisory: Zoneminder
Successful exploitation of this vulnerability could result in full Remote Code Execution (RCE) as th…